Welcome to our dedicated page for Tempus AI SEC filings (Ticker: TEM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Parsing Tempus AI’s disclosures can feel like wading through genomic data tables and privacy footnotes. The company’s 10-K details algorithm training costs, HIPAA compliance spending, and the revenue split between lab diagnostics and data subscriptions—facts buried deep in legal language. If you have ever searched “Tempus AI SEC filings explained simply” or wondered how to track “Tempus AI insider trading Form 4 transactions,” you know the challenge.
Stock Titan resolves it. Our platform delivers real-time alerts the moment a “Tempus AI quarterly earnings report 10-Q filing” or a sudden “Tempus AI 8-K material events explained” document hits EDGAR. AI-powered summaries translate every section, so understanding Tempus AI SEC documents with AI takes minutes, not hours. Need to spot leadership sentiment? We surface “Tempus AI Form 4 insider transactions real-time” alongside concise context. Looking at compensation? The “Tempus AI proxy statement executive compensation” highlights are pre-tagged.
Investors use these insights to gauge R&D intensity, evaluate data-licensing momentum, and monitor “Tempus AI executive stock transactions Form 4.” Whether you seek a “Tempus AI annual report 10-K simplified” overview or a single line item like cloud-hosting spend, our AI points you there. Key uses include:
- Compare segment revenue across consecutive 10-Q reports
- Track insider buying before product launches
- Review risk-factor updates tied to evolving health-data regulations
Stop scrolling endless PDFs—get “Tempus AI earnings report filing analysis” in plain language, updated the instant Tempus AI posts.
Tempus AI (TEM) Q2 2025 10-Q highlights:
- Revenue doubled to $314.6 M (+89% YoY); Genomics up 115% to $241.8 M and Data & Services up 36% to $72.8 M.
- Losses narrowed sharply. Net loss was $42.8 M vs. $552.2 M prior-year; loss per share improved to $(0.25) from $(6.86). Six-month loss fell 82% to $110.9 M.
- Margin trend: Gross margin rose to 62.0% from 45.5% as revenue growth outpaced cost of revenue.
- Cash flow improving. Operating cash outflow was $61.5 M versus $198.5 M YoY.
- Balance sheet transformed by M&A. Ambry Genetics acquisition (closed Feb 2025) added $695 M in assets, boosting goodwill/intangibles to $713 M. Total assets $1.63 B (+76% YTD); equity $309.6 M vs. $56.3 M at YE-24.
- Leverage increased. Long-term debt rose to $471.7 M (including new $100 M revolver); convertible note now $226.3 M. Cash & equivalents declined to $186.3 M from $341.0 M due to acquisition spend.
- The company remains an emerging growth company but expects to become a large accelerated filer as of year-end 2025.
Outlook implications: Rapid top-line expansion and integration of Ambry broaden TEM’s test menu and dataset, but higher leverage and ongoing losses keep profitability and liquidity key watch points.
Tempus AI, Inc. (Nasdaq: TEM) furnished a Form 8-K stating that on August 8, 2025 the company issued a press release with its financial results for the quarter ended June 30, 2025, which is furnished as Exhibit 99.1. The company also made supplemental financial information and a letter from its Chief Executive Officer and Chief Financial Officer available on the "Events" page of its investor relations website at http://investors.tempus.com. The filing explicitly states these materials are furnished, not filed, and includes Exhibit 104, the Cover Page Interactive Data File (Inline XBRL). The Form 8-K is signed by James Rogers, Chief Financial Officer, and the registrant is identified as an emerging growth company with Class A common stock trading under the symbol TEM on The Nasdaq Stock Market.
Tempus AI (TEM) Form 4: CEO/Chairman Eric P. Lefkofsky reported the sale of 166,250 Class A shares on 28-Jul-2025 under a Rule 10b5-1 trading plan adopted 4-Mar-2025.
- Gray Media, LLC – 33,250 shares sold at weighted averages of $62.16-$65.23; post-sale position: 9,274,033 shares.
- Blue Media, LLC – 133,000 shares sold at the same price ranges; post-sale position: 18,135,469 shares.
After these transactions, Lefkofsky remains the beneficial owner of ~39.8 million shares (2.04 M direct, 27.4 M via Gray/Blue Media and 10 M through a 2025 GRAT plus smaller entities), preserving an overwhelming majority of his stake.
No derivative transactions were reported. The filing notes that detailed price breakdowns are available upon request and that some direct shares were recently transferred to Blue Media.
Takeaway: While any insider sale by the founder can draw attention, the divested amount equals ≈0.4 % of his disclosed holdings, suggesting portfolio rebalancing rather than a meaningful reduction in commitment.
FAQ
What is the current stock price of Tempus AI (TEM)?
What is the market cap of Tempus AI (TEM)?
